Infant botulism in Australia: Availability of human botulinum antitoxin for treatment

Medical Journal of Australia

Volumn 193, Issue 10, 2010, Pages 614-615

  May, Meryta L A ^a   Corkeron, Michael A ^b   Stretton, Mark ^c  

^a MATER CHILDREN S HOSPITAL   (Australia)

^b QUEENSLAND HEALTH   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BABYBIG; BOTULINUM TOXIN; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; ANOREXIA; ARTICLE; ARTIFICIAL VENTILATION; BIOASSAY; BOTULISM; CASE REPORT; DEHYDRATION; FEMALE; HUMAN; INFANT; INTUBATION; LETHARGY; MOTOR DYSFUNCTION; MUSCLE STRENGTH; MUSCLE TONE; PEDIATRIC PHYSIOTHERAPY; PTOSIS;

EID: 78649642685     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb04073.x     Document Type: Article

References (4)

1. Australian Government Department of Health and Ageing. National Notifiable Diseases Network Surveillance System. http://www9.health.gov.au/cda/ source/Rpt-4.cfm (accessed Mar 2010).
2. Arnon S. Creation and development of the public service orphan drug human botulism immune globulin. Pediatrics 2007; 119: 785-790.
3. Arnon S, Schechter R, Maslanka S, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006; 354: 462-471. (Pubitemid 43200297)
4. Fransisco AM, Arnon S. Clinical mimics of infant botulism. Pediatrics 2007; 119: 826-828.